Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation

Allogeneic hematopoietic cell transplantation (HCT) offers a possible cure for patients with relapsed and refractory non-Hodgkin lymphoma (NHL) through potentially beneficial graft versus lymphoma effects. However, allogeneic HCT is associated with high nonrelapse mortality (NRM). Fludarabine with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamijo, Kimimori, Shimomura, Yoshimitsu, Shinohara, Akihito, Mizuno, Shohei, Kanaya, Minoru, Usui, Yoshiaki, Kim, Sung-Won, Ara, Takahide, Mizuno, Ishikazu, Kuriyama, Takuro, Nakazawa, Hideyuki, Matsuoka, Ken-ichi, Kusumoto, Shigeru, Maseki, Nobuo, Yamaguchi, Masaki, Ashida, Takashi, Onizuka, Makoto, Fukuda, Takahiro, Atsuta, Yoshiko, Kondo, Eisei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977852/
https://www.ncbi.nlm.nih.gov/pubmed/36631705
http://dx.doi.org/10.1007/s00277-023-05084-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977852/
https://www.ncbi.nlm.nih.gov/pubmed/36631705
http://dx.doi.org/10.1007/s00277-023-05084-x

Ejemplares similares